PGY2 Pharmacy Oncology Program

The PGY2 pharmacy residency program builds on the Doctor of Pharmacy education and PGY1 pharmacy residency program to contribute to the development of oncology clinical pharmacists in advanced or specialized practice. The Memorial Regional Hospital/Memorial Cancer Institute PGY2 residency will provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy.

The goal is that residents who successfully complete the Oncology Pharmacy PGY2 pharmacy residency program will possess the competencies that qualify them for Hematology/Oncology clinical pharmacist and/or faculty positions and position them to be eligible to attain Board Certification in Oncology Pharmacy (BCOP).

Positions available:

  • 2 positions (NMS Code 725660)

View our Oncology Pharmacy Program brochure (PDF).

Educational Experience

Learning Experiences

  • Oncology clinical operations
  • Adult inpatient hematology and oncology
  • Ambulatory care hematology and oncology
  • Women’s breast health oncology
  • Administration/Investigational drug service
  • Pediatric hematology and oncology
  • Malignant hematology and cellular therapy
  • Elective options include specialty pharmacy, investigational drug service, pain and palliative care and oncology administration, etc.

Longitudinal Experiences

  • Oncology pharmacy administration
  • Formulary management
    • Medication safety and quality
    • Medication use evaluation
  • Residency research project
  • Teaching and presentations
    • Co-precept pharmacy students and PGY1 residents
    • Continuing education and formal presentations
  • Oral chemotherapy pharmacy clinic
  • Oncology clinical operations (Staffing)

Program Preceptors

The Oncology Pharmacy PGY2 Program Preceptors are a diverse group of dedicated oncology clinicians with experience in oncology pharmacy practice ranging from 1 year to 30 years. More than 70% of the PGY2 program preceptors are board certified in at least one specialty area, and more than half completed PGY2 training. They have all met American Society of Health-System Pharmacists (ASHP) oncology pharmacy program preceptor eligibility criteria or are preceptors in training. In addition to the PGY2 core preceptors, the residents will work with, and be mentored by, other oncology pharmacists at Memorial Healthcare System.

Contact Us

Dina B. Dumercy, PharmD., BCOP, BCPS
Director - Oncology Pharmacy PGY2 Residency Program